Astrana Health Inc. Common Stock (ASTH) is a publicly traded Healthcare sector company. As of November 5, 2026, ASTH trades at $38.00 with a market cap of $1.97B and a P/E ratio of 79.74. ASTH moved -1.89% today. Year to date, ASTH is +42.04%; over the trailing twelve months it is +17.09%. Its 52-week range spans $18.08 to $51.60. Analyst consensus is strong buy with an average price target of $52.40. Rallies surfaces ASTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Astrana Health Q3 results beat EPS estimates; forecasts Q4 revenue of $939 million to $1.04 billion: Astrana Health's third-quarter revenue rose 7% to $1.02 billion, in line with estimates, while adjusted EPS rose 4% to $0.71 and adjusted EBITDA increased 13% to $77.2 million. The company expects fourth-quarter revenue of $939 million to $1.04 billion and adjusted EBITDA of $48.5 million to $61.5 million.
| Metric | Value |
|---|---|
| Price | $38.00 |
| Market Cap | $1.97B |
| P/E Ratio | 79.74 |
| EPS | $0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $51.60 |
| 52-Week Low | $18.08 |
| Volume | 427.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.18B |
| Net Income | $24.08M |
| Gross Margin | 0.00% |
8 analysts cover ASTH: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.40.